These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2462830)

  • 1. Attenuated T-lymphocyte lines as vaccinating agents against experimental autoimmune encephalomyelitis.
    Offner H; Jones R; Vandenbark AA
    Ann N Y Acad Sci; 1988; 540():540-2. PubMed ID: 2462830
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis.
    Lider O; Reshef T; Beraud E; Ben-Nun A; Cohen IR
    Science; 1988 Jan; 239(4836):181-3. PubMed ID: 2447648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein.
    Ben-Nun A; Wekerle H; Cohen IR
    Nature; 1981 Jul; 292(5818):60-1. PubMed ID: 6974307
    [No Abstract]   [Full Text] [Related]  

  • 4. Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells.
    Lohse AW; Mor F; Karin N; Cohen IR
    Science; 1989 May; 244(4906):820-2. PubMed ID: 2471264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological basis of T-cell vaccination against autoimmune disease.
    Cohen IR
    Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 2():879-84. PubMed ID: 2484252
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation.
    Beeton C; Barbaria J; Giraud P; Devaux J; Benoliel AM; Gola M; Sabatier JM; Bernard D; Crest M; Béraud E
    J Immunol; 2001 Jan; 166(2):936-44. PubMed ID: 11145670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A suppressor cell line that prevents the adoptive transfer of EAE in Lewis rats.
    Ellerman K; Brostoff S
    Ann N Y Acad Sci; 1988; 540():364-6. PubMed ID: 2462813
    [No Abstract]   [Full Text] [Related]  

  • 8. Pillars Article: The Rapid Isolation of Clonable Antigen-specific T Lymphocyte Lines Capable of Mediating Autoimmune Encephalomyelitis.
    Ben-Nun A; Wekerle H; Cohen IR
    J Immunol; 2017 May; 198(9):3384-3388. PubMed ID: 28416716
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulation of encephalitogenic T cells with recombinant TCR ligands.
    Burrows GG; Adlard KL; Bebo BF; Chang JW; Tenditnyy K; Vandenbark AA; Offner H
    J Immunol; 2000 Jun; 164(12):6366-71. PubMed ID: 10843691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against experimental autoimmune diseases using T lymphocytes treated with hydrostatic pressure.
    Lider O; Shinitzky M; Cohen IR
    Ann N Y Acad Sci; 1986; 475():267-73. PubMed ID: 2431645
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatments targeting the T cell receptor (TCR): effects of TCR peptide-specific T cells on activation, migration, and encephalitogenicity of myelin basic protein-specific T cells.
    Offner H; Jacobs R; Bebo BF; Vandenbark AA
    Springer Semin Immunopathol; 1999; 21(1):77-90. PubMed ID: 10389233
    [No Abstract]   [Full Text] [Related]  

  • 12. A myelin basic protein-specific T lymphocyte line that mediates experimental autoimmune encephalomyelitis.
    Vandenbark AA; Gill T; Offner H
    J Immunol; 1985 Jul; 135(1):223-8. PubMed ID: 2582032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active and passive experimental autoimmune encephalomyelitis in strain 129/J (H-2b) mice.
    Fritz RB; Zhao ML
    J Neurosci Res; 1996 Aug; 45(4):471-4. PubMed ID: 8872908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T cells in experimental allergic encephalomyelitis. I. Frequency and specificity analysis in normal and immune rats of a T cell subset that inhibits disease.
    Sun D; Whitaker JN; Wilson DB
    Int Immunol; 1999 Mar; 11(3):307-15. PubMed ID: 10221642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune encephalomyelitis (EAE) mediated or prevented by T lymphocyte lines directed against diverse antigenic determinants of myelin basic protein. Vaccination is determinant specific.
    Holoshitz J; Frenkel A; Ben-Nun A; Cohen IR
    J Immunol; 1983 Dec; 131(6):2810-3. PubMed ID: 6196400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of autoimmune reactions to myelin basic protein in measles virus encephalitis in Lewis rats.
    Liebert UG; Linington C; ter Meulen V
    J Neuroimmunol; 1988 Jan; 17(2):103-18. PubMed ID: 2447122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell vaccination prevents EAE effector cell development but does not inhibit priming of MBP responsive cells.
    Bouwer HG; Hinrichs DJ
    J Neurosci Res; 1996 Aug; 45(4):455-62. PubMed ID: 8872906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination against experimental autoimmune encephalomyelitis using a subencephalitogenic dose of autoimmune effector cells (1). Characteristics of vaccination.
    Beraud E; Lider O; Baharav E; Reshef T; Cohen IR
    J Autoimmun; 1989 Feb; 2(1):75-86. PubMed ID: 2473764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infusion of soluble myelin basic protein protects long-term against induction of experimental autoimmune encephalomyelitis.
    Staykova MA; Simmons RD; Willenborg DO
    Immunol Cell Biol; 1997 Feb; 75(1):54-64. PubMed ID: 9046435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T lymphocyte lines in the study of autoimmune disease.
    Wekerle H; Fierz W
    Blut; 1984 Sep; 49(3):187-94. PubMed ID: 6206905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.